Logos Global Management LP 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-13 6:53 pm Purchase |
2024-08-09 | 13D | Design Therapeutics, Inc. DSGN |
Logos Global Management LP | 4,232,627 7.500% |
1,420,126 (+50.49%) |
Filing |
| 2022-03-31 4:23 pm Purchase |
2022-03-21 | 13D | Design Therapeutics, Inc. DSGN |
Logos Global Management LP | 2,812,501 5.000% |
2,812,501 (New Position) |
Filing |